Quantitative Analysis of the Role of Patents and Drug Approvals in Drug Lifecycle Management in Japan.
- Published in:
- Pharmaceutical Medicine, 2016, v. 30, n. 3, p. 157, doi. 10.1007/s40290-016-0141-y
- By:
- Publication type:
- Article
Works in Pharmaceutical Medicine, 2016, Vol 30, Issue 3
Results: 8
1
2
Content Related to Older Adults in Canadian Innovator-Drug Product Monographs: An Exploratory Analysis.
- Published in:
- Pharmaceutical Medicine, 2016, v. 30, n. 3, p. 149, doi. 10.1007/s40290-016-0142-x
- By:
- Publication type:
- Article
3
The Francis Crick Institute: Scientific Discovery Open to Translation.
- Published in:
- Pharmaceutical Medicine, 2016, v. 30, n. 3, p. 133, doi. 10.1007/s40290-016-0143-9
- By:
- Publication type:
- Article
4
Andrew J. Krentz, Lutz Heinemann, Marcus Hompesch (Eds). Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development: A Focus on Early Phase Clinical Studies.
- Published in:
- Pharmaceutical Medicine, 2016, v. 30, n. 3, p. 165, doi. 10.1007/s40290-016-0144-8
- By:
- Publication type:
- Article
5
The Future of Pharmacovigilance: Proposals for More Efficient and Effective Systems-Based Approaches.
- Published in:
- Pharmaceutical Medicine, 2016, v. 30, n. 3, p. 137, doi. 10.1007/s40290-016-0145-7
- By:
- Publication type:
- Article
6
Forum.
- Published in:
- Pharmaceutical Medicine, 2016, v. 30, n. 3, p. 169, doi. 10.1007/s40290-016-0147-5
- Publication type:
- Article
7
Major Pharmaceutical Conferences and Courses.
- Published in:
- Pharmaceutical Medicine, 2016, v. 30, n. 3, p. 183, doi. 10.1007/s40290-016-0148-4
- Publication type:
- Article
8
Dose-Seeking Phase I Trials for Currently Approved Molecular-Targeted Therapies in the USA: The Dose-Limiting Toxicity Definition Issue.
- Published in:
- Pharmaceutical Medicine, 2016, v. 30, n. 3, p. 143, doi. 10.1007/s40290-016-0138-6
- By:
- Publication type:
- Article